Individual intestinal symbionts induce a distinct population of RORγ + regulatory T cells

Author:

Sefik Esen1,Geva-Zatorsky Naama1,Oh Sungwhan1,Konnikova Liza2,Zemmour David1,McGuire Abigail Manson3,Burzyn Dalia1,Ortiz-Lopez Adriana1,Lobera Mercedes4,Yang Jianfei4,Ghosh Shomir4,Earl Ashlee3,Snapper Scott B.2,Jupp Ray5,Kasper Dennis1,Mathis Diane16,Benoist Christophe16

Affiliation:

1. Division of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston 02115, MA, USA.

2. Division of Gastroenterology and Hepatology, Brigham and Women's Hospital, Boston, MA 02115, USA, and Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.

3. Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

4. Tempero Pharmaceuticals, a GSK Company, Cambridge, MA 02115, USA.

5. UCB Pharma, Slough, Berkshire, UK.

6. Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women’s Hospital, Boston, MA 02115, USA.

Abstract

Gut microbes make T cells keep the peace Our guts harbor trillions of microbial inhabitants, some of which regulate the types of immune cells that are present in the gut. For instance, Clostridium species of bacteria induce a type of T cell that promotes tolerance between the host and its microbial contents. Ohnmacht et al. and Sefik et al. characterized a population of gut regulatory T cells in mice, which required gut microbiota to survive. Multiple bacterial species of the microbiota could induce transcription factor–expressing regulatory T cells that helped maintain immune homeostasis. Mice engineered to lack these transcription factors exhibited enhanced susceptibility to colonic inflammation and had elevated amounts of proinflammatory molecules associated with allergies (see the Perspective by Hegazy and Powrie). Science , this issue pp. 989 and 993

Funder

NIH

European Molecular Biology Organization

Human Frontier Science Program

Helmsley Charitable Trust

Boehringer Ingelheim Fonds

J.P.B. Foundation

UCB Pharma

Center for Inflammatory Bowel Disease Treatment and Research

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3